RedHotStocks

$MBRX DO NOT RULE IT OUT QUITE YET DESPITE NEW OFFERING.

NASDAQ:MBRX   Moleculin Biotech, Inc.
Yesterdays gainers are quickly forgotten, up 170% on the 4/22/19 and loses drops 50% on 4/23/19 on news of new offering. Despite this a great opportunity may still exist in the name, tomorrow there is still scheduled call to announce developments in FDA approval and possible positive results from its new lung cancer drug.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.